Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
Cardio Diagnostics Holdings Inc. - Common stock (CDIO)
Company Research
Source: Business Wire
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at Family Medicine Specialists’ (FMS) retail clinical location at the Meijer Supercenter in McHenry, Illinois.Expanding Access in the MidwestMeijer, a privately owned and family-operated retailer based in Michigan, has more than 500 locations in the heartland of America. The company’s consumers are predominately middle-aged and older adults in suburban and rural areas of the Midwest. Given that 73% of Meijer shoppers are within the Gen X and Boomers age groups of 45-years old and older, it is crucial to address the health needs of this demographic, particularly concerning heart disease.According to the American Heart Association, heart disease is the leading cause of death among men and women, including those aged 45 and older, making cardiovascular health a significa
Show less
Read more
Impact Snapshot
Event Time:
CDIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDIO alerts
High impacting Cardio Diagnostics Holdings Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CDIO
News
- Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics ForumBusiness Wire
- Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and ConfidentialityBusiness Wire
- Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) had its price target raised by analysts at Benchmark Co. from $1.35 to $2.00. They now have a "speculative buy" rating on the stock.MarketBeat
- Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative TestsBusiness Wire
- Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a WeekBusiness Wire
CDIO
Sec Filings
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- CDIO's page on the SEC website